aluates Reports

$ 0.0

Automative

Global Humanized Monoclonal Antibody Market Research Report 2024

Published Date: September 2024

Report Code: QYRE-Auto-16D18157

BUY CHAPTERS

Global Humanized Monoclonal Antibody Market Research Report 2024

Code: QYRE-Auto-16D18157

Report

September 2024

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Absolute Antibody

Amgen Inc

Biotem

Creative-Biolabs

Genentech Inc

GenScript ProBio

Huston BioConsulting LLC

ImmunoGen Inc

MorphoSys

MRC Laboratory of Molecular Biology

ProMab Biotechnologies

ProteoGenix

Sandoz International

Seattle Genetics

Zyngenia

Humanized Monoclonal Antibody Market Size

The global Humanized Monoclonal Antibody market was valued at US$ 8561 million in 2023 and is anticipated to reach US$ 17790 million by 2030, witnessing a CAGR of 11.6% during the forecast period 2024-2030.

Humanized Monoclonal Antibody Market

Humanized Monoclonal Antibody is a type of antibody engineered to closely resemble human antibodies while retaining the specificity of a non-human source. This process involves modifying a monoclonal antibody, originally derived from animal sources (often mice), by grafting its variable regions onto a human antibody framework. The result is an antibody that can effectively target specific antigens while minimizing the risk of immune reactions against the antibody itself, making it safer and more effective for therapeutic use in humans, such as in the treatment of various diseases including cancer and autoimmune disorders.

North American market for Humanized Monoclonal Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Humanized Monoclonal Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Humanized Monoclonal Antibody in Laboratory Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Humanized Monoclonal Antibody include Absolute Antibody, Amgen, Biotem, Creative Biolabs, Genentech, GenScript ProBio, Huston BioConsulting LLC, ImmunoGen, MorphoSys, MRC Laboratory of Molecular Biology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Humanized Monoclonal Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Humanized Monoclonal Antibody.

The Humanized Monoclonal Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Humanized Monoclonal Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Humanized Monoclonal Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Humanized Monoclonal Antibody Market Report

Report Metric	Details
Report Name	Humanized Monoclonal Antibody Market
Accounted market size in 2023	US$ 8561 million
Forecasted market size in 2030	US$ 17790 million
CAGR	11.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Fully Humanized Antibody Humanized Antibody Chimeric Antibody
Segment by Application	Laboratory Research Clinical Drugs
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Absolute Antibody, Amgen, Biotem, Creative Biolabs, Genentech, GenScript ProBio, Huston BioConsulting LLC, ImmunoGen, MorphoSys, MRC Laboratory of Molecular Biology, ProMab Biotechnologies, ProteoGenix, Sandoz International, Seattle Genetics, Zyngenia
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Humanized Monoclonal Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Humanized Monoclonal Antibody Market growing?

Ans: The Humanized Monoclonal Antibody Market witnessing a CAGR of 11.6% during the forecast period 2024-2030.

What is the Humanized Monoclonal Antibody Market size in 2030?

Ans: The Humanized Monoclonal Antibody Market size in 2030 will be US$ 17790 million.

Who are the main players in the Humanized Monoclonal Antibody Market report?

Ans: The main players in the Humanized Monoclonal Antibody Market are Absolute Antibody, Amgen, Biotem, Creative Biolabs, Genentech, GenScript ProBio, Huston BioConsulting LLC, ImmunoGen, MorphoSys, MRC Laboratory of Molecular Biology, ProMab Biotechnologies, ProteoGenix, Sandoz International, Seattle Genetics, Zyngenia

What are the Application segmentation covered in the Humanized Monoclonal Antibody Market report?

Ans: The Applications covered in the Humanized Monoclonal Antibody Market report are Laboratory Research, Clinical Drugs

What are the Type segmentation covered in the Humanized Monoclonal Antibody Market report?

Ans: The Types covered in the Humanized Monoclonal Antibody Market report are Fully Humanized Antibody, Humanized Antibody, Chimeric Antibody

Recommended Reports

Antibody Therapeutics

Antibody Diagnostics

Immunotherapy Markets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Humanized Monoclonal Antibody Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Fully Humanized Antibody

1.2.3 Humanized Antibody

1.2.4 Chimeric Antibody

1.3 Market by Application

1.3.1 Global Humanized Monoclonal Antibody Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Laboratory Research

1.3.3 Clinical Drugs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Humanized Monoclonal Antibody Market Perspective (2019-2030)

2.2 Global Humanized Monoclonal Antibody Growth Trends by Region

2.2.1 Global Humanized Monoclonal Antibody Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Humanized Monoclonal Antibody Historic Market Size by Region (2019-2024)

2.2.3 Humanized Monoclonal Antibody Forecasted Market Size by Region (2025-2030)

2.3 Humanized Monoclonal Antibody Market Dynamics

2.3.1 Humanized Monoclonal Antibody Industry Trends

2.3.2 Humanized Monoclonal Antibody Market Drivers

2.3.3 Humanized Monoclonal Antibody Market Challenges

2.3.4 Humanized Monoclonal Antibody Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Humanized Monoclonal Antibody Players by Revenue

3.1.1 Global Top Humanized Monoclonal Antibody Players by Revenue (2019-2024)

3.1.2 Global Humanized Monoclonal Antibody Revenue Market Share by Players (2019-2024)

3.2 Global Humanized Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Humanized Monoclonal Antibody Revenue

3.4 Global Humanized Monoclonal Antibody Market Concentration Ratio

3.4.1 Global Humanized Monoclonal Antibody Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Humanized Monoclonal Antibody Revenue in 2023

3.5 Global Key Players of Humanized Monoclonal Antibody Head office and Area Served

3.6 Global Key Players of Humanized Monoclonal Antibody, Product and Application

3.7 Global Key Players of Humanized Monoclonal Antibody, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Humanized Monoclonal Antibody Breakdown Data by Type

4.1 Global Humanized Monoclonal Antibody Historic Market Size by Type (2019-2024)

4.2 Global Humanized Monoclonal Antibody Forecasted Market Size by Type (2025-2030)

5 Humanized Monoclonal Antibody Breakdown Data by Application

5.1 Global Humanized Monoclonal Antibody Historic Market Size by Application (2019-2024)

5.2 Global Humanized Monoclonal Antibody Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Humanized Monoclonal Antibody Market Size (2019-2030)

6.2 North America Humanized Monoclonal Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Humanized Monoclonal Antibody Market Size by Country (2019-2024)

6.4 North America Humanized Monoclonal Antibody Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Humanized Monoclonal Antibody Market Size (2019-2030)

7.2 Europe Humanized Monoclonal Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Humanized Monoclonal Antibody Market Size by Country (2019-2024)

7.4 Europe Humanized Monoclonal Antibody Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Humanized Monoclonal Antibody Market Size (2019-2030)

8.2 Asia-Pacific Humanized Monoclonal Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Humanized Monoclonal Antibody Market Size by Region (2019-2024)

8.4 Asia-Pacific Humanized Monoclonal Antibody Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Humanized Monoclonal Antibody Market Size (2019-2030)

9.2 Latin America Humanized Monoclonal Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Humanized Monoclonal Antibody Market Size by Country (2019-2024)

9.4 Latin America Humanized Monoclonal Antibody Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Humanized Monoclonal Antibody Market Size (2019-2030)

10.2 Middle East & Africa Humanized Monoclonal Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Humanized Monoclonal Antibody Market Size by Country (2019-2024)

10.4 Middle East & Africa Humanized Monoclonal Antibody Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Absolute Antibody

11.1.1 Absolute Antibody Company Details

11.1.2 Absolute Antibody Business Overview

11.1.3 Absolute Antibody Humanized Monoclonal Antibody Introduction

11.1.4 Absolute Antibody Revenue in Humanized Monoclonal Antibody Business (2019-2024)

11.1.5 Absolute Antibody Recent Development

11.2 Amgen

11.2.1 Amgen Company Details

11.2.2 Amgen Business Overview

11.2.3 Amgen Humanized Monoclonal Antibody Introduction

11.2.4 Amgen Revenue in Humanized Monoclonal Antibody Business (2019-2024)

11.2.5 Amgen Recent Development

11.3 Biotem

11.3.1 Biotem Company Details

11.3.2 Biotem Business Overview

11.3.3 Biotem Humanized Monoclonal Antibody Introduction

11.3.4 Biotem Revenue in Humanized Monoclonal Antibody Business (2019-2024)

11.3.5 Biotem Recent Development

11.4 Creative Biolabs

11.4.1 Creative Biolabs Company Details

11.4.2 Creative Biolabs Business Overview

11.4.3 Creative Biolabs Humanized Monoclonal Antibody Introduction

11.4.4 Creative Biolabs Revenue in Humanized Monoclonal Antibody Business (2019-2024)

11.4.5 Creative Biolabs Recent Development

11.5 Genentech

11.5.1 Genentech Company Details

11.5.2 Genentech Business Overview

11.5.3 Genentech Humanized Monoclonal Antibody Introduction

11.5.4 Genentech Revenue in Humanized Monoclonal Antibody Business (2019-2024)

11.5.5 Genentech Recent Development

11.6 GenScript ProBio

11.6.1 GenScript ProBio Company Details

11.6.2 GenScript ProBio Business Overview

11.6.3 GenScript ProBio Humanized Monoclonal Antibody Introduction

11.6.4 GenScript ProBio Revenue in Humanized Monoclonal Antibody Business (2019-2024)

11.6.5 GenScript ProBio Recent Development

11.7 Huston BioConsulting LLC

11.7.1 Huston BioConsulting LLC Company Details

11.7.2 Huston BioConsulting LLC Business Overview

11.7.3 Huston BioConsulting LLC Humanized Monoclonal Antibody Introduction

11.7.4 Huston BioConsulting LLC Revenue in Humanized Monoclonal Antibody Business (2019-2024)

11.7.5 Huston BioConsulting LLC Recent Development

11.8 ImmunoGen

11.8.1 ImmunoGen Company Details

11.8.2 ImmunoGen Business Overview

11.8.3 ImmunoGen Humanized Monoclonal Antibody Introduction

11.8.4 ImmunoGen Revenue in Humanized Monoclonal Antibody Business (2019-2024)

11.8.5 ImmunoGen Recent Development

11.9 MorphoSys

11.9.1 MorphoSys Company Details

11.9.2 MorphoSys Business Overview

11.9.3 MorphoSys Humanized Monoclonal Antibody Introduction

11.9.4 MorphoSys Revenue in Humanized Monoclonal Antibody Business (2019-2024)

11.9.5 MorphoSys Recent Development

11.10 MRC Laboratory of Molecular Biology

11.10.1 MRC Laboratory of Molecular Biology Company Details

11.10.2 MRC Laboratory of Molecular Biology Business Overview

11.10.3 MRC Laboratory of Molecular Biology Humanized Monoclonal Antibody Introduction

11.10.4 MRC Laboratory of Molecular Biology Revenue in Humanized Monoclonal Antibody Business (2019-2024)

11.10.5 MRC Laboratory of Molecular Biology Recent Development

11.11 ProMab Biotechnologies

11.11.1 ProMab Biotechnologies Company Details

11.11.2 ProMab Biotechnologies Business Overview

11.11.3 ProMab Biotechnologies Humanized Monoclonal Antibody Introduction

11.11.4 ProMab Biotechnologies Revenue in Humanized Monoclonal Antibody Business (2019-2024)

11.11.5 ProMab Biotechnologies Recent Development

11.12 ProteoGenix

11.12.1 ProteoGenix Company Details

11.12.2 ProteoGenix Business Overview

11.12.3 ProteoGenix Humanized Monoclonal Antibody Introduction

11.12.4 ProteoGenix Revenue in Humanized Monoclonal Antibody Business (2019-2024)

11.12.5 ProteoGenix Recent Development

11.13 Sandoz International

11.13.1 Sandoz International Company Details

11.13.2 Sandoz International Business Overview

11.13.3 Sandoz International Humanized Monoclonal Antibody Introduction

11.13.4 Sandoz International Revenue in Humanized Monoclonal Antibody Business (2019-2024)

11.13.5 Sandoz International Recent Development

11.14 Seattle Genetics

11.14.1 Seattle Genetics Company Details

11.14.2 Seattle Genetics Business Overview

11.14.3 Seattle Genetics Humanized Monoclonal Antibody Introduction

11.14.4 Seattle Genetics Revenue in Humanized Monoclonal Antibody Business (2019-2024)

11.14.5 Seattle Genetics Recent Development

11.15 Zyngenia

11.15.1 Zyngenia Company Details

11.15.2 Zyngenia Business Overview

11.15.3 Zyngenia Humanized Monoclonal Antibody Introduction

11.15.4 Zyngenia Revenue in Humanized Monoclonal Antibody Business (2019-2024)

11.15.5 Zyngenia Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Absolute Antibody

Amgen Inc

Biotem

Creative-Biolabs

Genentech Inc

GenScript ProBio

Huston BioConsulting LLC

ImmunoGen Inc

MorphoSys

MRC Laboratory of Molecular Biology

ProMab Biotechnologies

ProteoGenix

Sandoz International

Seattle Genetics

Zyngenia

List of Tables

Table 1. Global Humanized Monoclonal Antibody Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Fully Humanized Antibody

Table 3. Key Players of Humanized Antibody

Table 4. Key Players of Chimeric Antibody

Table 5. Global Humanized Monoclonal Antibody Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Humanized Monoclonal Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Humanized Monoclonal Antibody Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Humanized Monoclonal Antibody Market Share by Region (2019-2024)

Table 9. Global Humanized Monoclonal Antibody Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Humanized Monoclonal Antibody Market Share by Region (2025-2030)

Table 11. Humanized Monoclonal Antibody Market Trends

Table 12. Humanized Monoclonal Antibody Market Drivers

Table 13. Humanized Monoclonal Antibody Market Challenges

Table 14. Humanized Monoclonal Antibody Market Restraints

Table 15. Global Humanized Monoclonal Antibody Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Humanized Monoclonal Antibody Market Share by Players (2019-2024)

Table 17. Global Top Humanized Monoclonal Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Humanized Monoclonal Antibody as of 2023)

Table 18. Ranking of Global Top Humanized Monoclonal Antibody Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Humanized Monoclonal Antibody Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Humanized Monoclonal Antibody, Headquarters and Area Served

Table 21. Global Key Players of Humanized Monoclonal Antibody, Product and Application

Table 22. Global Key Players of Humanized Monoclonal Antibody, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Humanized Monoclonal Antibody Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Humanized Monoclonal Antibody Revenue Market Share by Type (2019-2024)

Table 26. Global Humanized Monoclonal Antibody Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Humanized Monoclonal Antibody Revenue Market Share by Type (2025-2030)

Table 28. Global Humanized Monoclonal Antibody Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Humanized Monoclonal Antibody Revenue Market Share by Application (2019-2024)

Table 30. Global Humanized Monoclonal Antibody Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Humanized Monoclonal Antibody Revenue Market Share by Application (2025-2030)

Table 32. North America Humanized Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Humanized Monoclonal Antibody Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Humanized Monoclonal Antibody Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Humanized Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Humanized Monoclonal Antibody Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Humanized Monoclonal Antibody Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Humanized Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Humanized Monoclonal Antibody Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Humanized Monoclonal Antibody Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Humanized Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Humanized Monoclonal Antibody Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Humanized Monoclonal Antibody Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Humanized Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Humanized Monoclonal Antibody Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Humanized Monoclonal Antibody Market Size by Country (2025-2030) & (US$ Million)

Table 47. Absolute Antibody Company Details

Table 48. Absolute Antibody Business Overview

Table 49. Absolute Antibody Humanized Monoclonal Antibody Product

Table 50. Absolute Antibody Revenue in Humanized Monoclonal Antibody Business (2019-2024) & (US$ Million)

Table 51. Absolute Antibody Recent Development

Table 52. Amgen Company Details

Table 53. Amgen Business Overview

Table 54. Amgen Humanized Monoclonal Antibody Product

Table 55. Amgen Revenue in Humanized Monoclonal Antibody Business (2019-2024) & (US$ Million)

Table 56. Amgen Recent Development

Table 57. Biotem Company Details

Table 58. Biotem Business Overview

Table 59. Biotem Humanized Monoclonal Antibody Product

Table 60. Biotem Revenue in Humanized Monoclonal Antibody Business (2019-2024) & (US$ Million)

Table 61. Biotem Recent Development

Table 62. Creative Biolabs Company Details

Table 63. Creative Biolabs Business Overview

Table 64. Creative Biolabs Humanized Monoclonal Antibody Product

Table 65. Creative Biolabs Revenue in Humanized Monoclonal Antibody Business (2019-2024) & (US$ Million)

Table 66. Creative Biolabs Recent Development

Table 67. Genentech Company Details

Table 68. Genentech Business Overview

Table 69. Genentech Humanized Monoclonal Antibody Product

Table 70. Genentech Revenue in Humanized Monoclonal Antibody Business (2019-2024) & (US$ Million)

Table 71. Genentech Recent Development

Table 72. GenScript ProBio Company Details

Table 73. GenScript ProBio Business Overview

Table 74. GenScript ProBio Humanized Monoclonal Antibody Product

Table 75. GenScript ProBio Revenue in Humanized Monoclonal Antibody Business (2019-2024) & (US$ Million)

Table 76. GenScript ProBio Recent Development

Table 77. Huston BioConsulting LLC Company Details

Table 78. Huston BioConsulting LLC Business Overview

Table 79. Huston BioConsulting LLC Humanized Monoclonal Antibody Product

Table 80. Huston BioConsulting LLC Revenue in Humanized Monoclonal Antibody Business (2019-2024) & (US$ Million)

Table 81. Huston BioConsulting LLC Recent Development

Table 82. ImmunoGen Company Details

Table 83. ImmunoGen Business Overview

Table 84. ImmunoGen Humanized Monoclonal Antibody Product

Table 85. ImmunoGen Revenue in Humanized Monoclonal Antibody Business (2019-2024) & (US$ Million)

Table 86. ImmunoGen Recent Development

Table 87. MorphoSys Company Details

Table 88. MorphoSys Business Overview

Table 89. MorphoSys Humanized Monoclonal Antibody Product

Table 90. MorphoSys Revenue in Humanized Monoclonal Antibody Business (2019-2024) & (US$ Million)

Table 91. MorphoSys Recent Development

Table 92. MRC Laboratory of Molecular Biology Company Details

Table 93. MRC Laboratory of Molecular Biology Business Overview

Table 94. MRC Laboratory of Molecular Biology Humanized Monoclonal Antibody Product

Table 95. MRC Laboratory of Molecular Biology Revenue in Humanized Monoclonal Antibody Business (2019-2024) & (US$ Million)

Table 96. MRC Laboratory of Molecular Biology Recent Development

Table 97. ProMab Biotechnologies Company Details

Table 98. ProMab Biotechnologies Business Overview

Table 99. ProMab Biotechnologies Humanized Monoclonal Antibody Product

Table 100. ProMab Biotechnologies Revenue in Humanized Monoclonal Antibody Business (2019-2024) & (US$ Million)

Table 101. ProMab Biotechnologies Recent Development

Table 102. ProteoGenix Company Details

Table 103. ProteoGenix Business Overview

Table 104. ProteoGenix Humanized Monoclonal Antibody Product

Table 105. ProteoGenix Revenue in Humanized Monoclonal Antibody Business (2019-2024) & (US$ Million)

Table 106. ProteoGenix Recent Development

Table 107. Sandoz International Company Details

Table 108. Sandoz International Business Overview

Table 109. Sandoz International Humanized Monoclonal Antibody Product

Table 110. Sandoz International Revenue in Humanized Monoclonal Antibody Business (2019-2024) & (US$ Million)

Table 111. Sandoz International Recent Development

Table 112. Seattle Genetics Company Details

Table 113. Seattle Genetics Business Overview

Table 114. Seattle Genetics Humanized Monoclonal Antibody Product

Table 115. Seattle Genetics Revenue in Humanized Monoclonal Antibody Business (2019-2024) & (US$ Million)

Table 116. Seattle Genetics Recent Development

Table 117. Zyngenia Company Details

Table 118. Zyngenia Business Overview

Table 119. Zyngenia Humanized Monoclonal Antibody Product

Table 120. Zyngenia Revenue in Humanized Monoclonal Antibody Business (2019-2024) & (US$ Million)

Table 121. Zyngenia Recent Development

Table 122. Research Programs/Design for This Report

Table 123. Key Data Information from Secondary Sources

Table 124. Key Data Information from Primary Sources

Table 125. Authors List of This Report

List of Figures

Figure 1. Humanized Monoclonal Antibody Picture

Figure 2. Global Humanized Monoclonal Antibody Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Humanized Monoclonal Antibody Market Share by Type: 2023 VS 2030

Figure 4. Fully Humanized Antibody Features

Figure 5. Humanized Antibody Features

Figure 6. Chimeric Antibody Features

Figure 7. Global Humanized Monoclonal Antibody Market Size by Application (2024-2030) & (US$ Million)

Figure 8. Global Humanized Monoclonal Antibody Market Share by Application: 2023 VS 2030

Figure 9. Laboratory Research Case Studies

Figure 10. Clinical Drugs Case Studies

Figure 11. Humanized Monoclonal Antibody Report Years Considered

Figure 12. Global Humanized Monoclonal Antibody Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Humanized Monoclonal Antibody Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Humanized Monoclonal Antibody Market Share by Region: 2023 VS 2030

Figure 15. Global Humanized Monoclonal Antibody Market Share by Players in 2023

Figure 16. Global Top Humanized Monoclonal Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Humanized Monoclonal Antibody as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Humanized Monoclonal Antibody Revenue in 2023

Figure 18. North America Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Humanized Monoclonal Antibody Market Share by Country (2019-2030)

Figure 20. United States Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Humanized Monoclonal Antibody Market Share by Country (2019-2030)

Figure 24. Germany Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Humanized Monoclonal Antibody Market Share by Region (2019-2030)

Figure 32. China Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Humanized Monoclonal Antibody Market Share by Country (2019-2030)

Figure 40. Mexico Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Humanized Monoclonal Antibody Market Share by Country (2019-2030)

Figure 44. Turkey Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. UAE Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Absolute Antibody Revenue Growth Rate in Humanized Monoclonal Antibody Business (2019-2024)

Figure 48. Amgen Revenue Growth Rate in Humanized Monoclonal Antibody Business (2019-2024)

Figure 49. Biotem Revenue Growth Rate in Humanized Monoclonal Antibody Business (2019-2024)

Figure 50. Creative Biolabs Revenue Growth Rate in Humanized Monoclonal Antibody Business (2019-2024)

Figure 51. Genentech Revenue Growth Rate in Humanized Monoclonal Antibody Business (2019-2024)

Figure 52. GenScript ProBio Revenue Growth Rate in Humanized Monoclonal Antibody Business (2019-2024)

Figure 53. Huston BioConsulting LLC Revenue Growth Rate in Humanized Monoclonal Antibody Business (2019-2024)

Figure 54. ImmunoGen Revenue Growth Rate in Humanized Monoclonal Antibody Business (2019-2024)

Figure 55. MorphoSys Revenue Growth Rate in Humanized Monoclonal Antibody Business (2019-2024)

Figure 56. MRC Laboratory of Molecular Biology Revenue Growth Rate in Humanized Monoclonal Antibody Business (2019-2024)

Figure 57. ProMab Biotechnologies Revenue Growth Rate in Humanized Monoclonal Antibody Business (2019-2024)

Figure 58. ProteoGenix Revenue Growth Rate in Humanized Monoclonal Antibody Business (2019-2024)

Figure 59. Sandoz International Revenue Growth Rate in Humanized Monoclonal Antibody Business (2019-2024)

Figure 60. Seattle Genetics Revenue Growth Rate in Humanized Monoclonal Antibody Business (2019-2024)

Figure 61. Zyngenia Revenue Growth Rate in Humanized Monoclonal Antibody Business (2019-2024)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Humanized Antibody Market Research Report 2024

Global Humanized Bispecific Antibody Market Research Report 2024

Global Humanized Bispecific Antibodies Market Research Report 2024

Global Therapeutic Monoclonal Antibodies Market Research Report 2024

Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024

Global Recombinant Rabbit Monoclonal Antibodies Market Research Report 2025

Monoclonal Antibody Biologics and Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Monoclonal Antibody Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biologics Monoclonal Antibodies Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Rabbit Monoclonal Antibody Service Market Research Report 2025

Global Monoclonal Antibody Development Services Market Research Report 2024

Global Monoclonal Antibody Drugs for Cancer Market Research Report 2024

Global Ipilimumab Market Research Report 2024

Global Arthritis Monoclonal Antibodies Market Research Report 2024

Global Next Generation Monoclonal Antibodies Market Research Report 2024

Global Tetanus Human Monoclonal Antibody Market Research Report 2024

Global Antibody Library Technology Market Research Report 2024

Fully Humanized Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Monoclonal Antibody Partnering Terms and Agreements Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions